Efficacy study of 6 MeV electron beam in the presence of magnetic iron oxide nanoparticles conjugated to cisplatin on B16F10 cells: an in-vitro study
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Radiation Therapy and Dosimetry · Nanoparticle-Based Drug Delivery · Radiation Shielding Materials Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. K. Saginala, A. Barsouk, J.S. Aluru, P. Rawla, A. Barsouk, Epidemiology of melanoma. Med. Sci. 9(4), 63 (2021)
2. L.E. Davis, S.C. Shalin, A.J. Tackett, Current state of melanoma diagnosis and treatment. Cancer Biol. Ther. 20(11), 1366–1379 (2019)10.1080/15384047.2019.1640032 ↗
3. B. Domingues, J. M. Lopes, P. Soares, and H. Pópulo, ImmunoTargets Ther. 7, 35 (2018).10.2147/ITT.S134842 ↗
4. R.E. Wegner, S. Abel, R.S. D’Amico, G.U. Mehta, J. Sheehan, Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome. J. Neurooncol. 152, 79–87 (2021)10.1007/s11060-020-03663-w ↗
5. M. Ralli, A. Botticelli, I.C. Visconti, D. Angeletti, M. Fiore, P. Marchetti et al., Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions. J Immunol Res. 2020;202010.1155/2020/9235638 ↗
6. K. Kokurewicz, E. Brunetti, A. Curcio, D. Gamba, L. Garolfi, A. Gilardi et al., An experimental study of focused very high energy electron beams for radiotherapy. Commun. Phys. 4(1), 33 (2021)10.1038/s42005-021-00536-0 ↗
7. E. Schüler, M. Acharya, P. Montay-Gruel, B.W. Jr Loo, M. Vozenin, P.G. Maxim, Ultra‐high dose rate electron beams and the FLASH effect: from preclinical evidence to a new radiotherapy paradigm. Med. Phys. 49(3), 2082–2095 (2022)10.1002/mp.15442 ↗
8. S. Takahashi, M. Anada, T. Kinoshita, T. Nishide, T. Shibata, Prospective exploratory study of the relationship between radiation pneumonitis and TGF-β1 in exhaled breath condensate. Vivo (Brooklyn). 36(3), 1485–1490 (2022)10.21873/invivo.12855 ↗
9. M. Fiorentzis, H. Kalirai, P. Katopodis, B. Seitz, A. Viestenz, S.E. Coupland, Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro. Neoplasma. 65(2), 210–215 (2018)10.4149/neo_2018_170329N227 ↗
10. P. Wróblewska-Łuczka, A. Grabarska, M. Florek-Łuszczki, Z. Plewa, J.J. Łuszczki, Synergy, additivity, and antagonism between cisplatin and selected coumarins in human melanoma cells. Int. J. Mol. Sci. 22(2), 537 (2021)10.3390/ijms22020537 ↗
11. I.W. Achkar, N. Abdulrahman, H. Al-Sulaiti, J.M. Joseph, S. Uddin, F. Mraiche, Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway. J. Transl Med. 16(1), 1–12 (2018)10.1186/s12967-018-1471-1 ↗
12. S. Sheth, D. Mukherjea, L.P. Rybak, V. Ramkumar, Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front. Cell. Neurosci. 11, 338 (2017)10.3389/fncel.2017.00338 ↗
13. R. Oun, Y.E. Moussa, N.J. Wheate, The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalt Trans. 47(19), 6645–6653 (2018)10.1039/C8DT00838H ↗
14. S. Manohar, N. Leung, Cisplatin nephrotoxicity: a review of the literature. J. Nephrol. 31(1), 15–25 (2018)10.1007/s40620-017-0392-z ↗
15. S. Malik, K. Muhammad, Y. Waheed, Nanotechnology, A revolution in modern industry. Molecules. 28(2), 661 (2023)10.3390/molecules28020661 ↗
16. D.A. Richards, A. Maruani, V. Chudasama, Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem. Sci. 8(1), 63–77 (2017)10.1039/C6SC02403C ↗
17. N. Elahi, M. Rizwan, Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: a review. Artif. Organs. 45(11), 1272–1299 (2021)10.1111/aor.14027 ↗
18. H.V. Tran, N.M. Ngo, R. Medhi, P. Srinoi, T. Liu, S. Rittikulsittichai et al., Multifunctional iron oxide magnetic nanoparticles for biomedical applications: a review. Mater. (Basel). 15(2), 503 (2022)10.3390/ma15020503 ↗
19. M.M. Swidan, O.M. Khowessah, M.A. El-Motaleb, A.A. El-Bary, M.T. El-Kolaly, T.M. Sakr, Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis. DARU. J. Pharm. Sci. 27(1), 49–58 (2019)
20. K. Reczyńska, M. Marszałek, A. Zarzycki, W. Reczyński, K. Kornaus, E. Pamuła et al., Superparamagnetic iron oxide nanoparticles modified with silica layers as potential agents for lung cancer treatment. Nanomaterials. 10(6), 1076 (2020)10.3390/nano10061076 ↗
21. N. Ohannesian, De C.T. Leo, K.S. Martirosyan, Dextran coated superparamagnetic iron oxide nanoparticles produced by microfluidic process. Mater Today Proc. 2019;13:397–40310.1016/j.matpr.2019.03.172 ↗
22. P. Kumar, S. Agnihotri, and I. Roy, Int. J. Nanomedicine 13, 43–45 (2018).10.2147/IJN.S125002 ↗
23. Y. Zhang, X. Han, Y. Liu, S. Wang, X. Han, C. Cheng, Research progress on nano-sensitizers for enhancing the effects of radiotherapy. Mater. Adv. 3(9), 3709–3725 (2022)10.1039/D2MA00094F ↗
24. D. Kwatra, A. Venugopal, S. Anant, Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer. Transl Cancer Res. 2(4), 330–342 (2013)
25. H. Fakhimikabir, M.B. Tavakoli, A. Zarrabi, A. Amouheidari, S. Rahgozar, The role of folic acid-conjugated polyglycerol coated iron oxide nanoparticles on radiosensitivity with clinical electron beam (6 MeV) on human cervical carcinoma cell line: in vitro study. J. Photochem. Photobiol., B 182, 71–76 (2018)10.1016/j.jphotobiol.2018.03.023 ↗
26. W.N. Rahman, S.N.M. Kadian, R. Ab Rashid, R. Abdullah, K.A. Razak, B.T.T. Pham et al., Radiosensitization characteristic of superparamagnetic iron oxide nanoparticles in electron beam radiotherapy and brachytherapy. In: Journal of Physics: Conference Series. IOP Publishing; 2019. p. 1206810.1088/1742-6596/1248/1/012068 ↗
27. E. Kucuksayan, F. Bozkurt, M.T. Yilmaz, A. Sircan-Kucuksayan, A. Hanikoglu, T. Ozben, A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers. Sci. Rep. 11(1), 13027 (2021)10.1038/s41598-021-92447-x ↗
28. L.M. Quan, Y. Zhong, H.H. Weng, Synthesis of cell penetrating peptide decorated magnetic nanoparticles loading cisplatin for nasopharyngeal cancer therapy. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = J Clin Otorhinolaryngol Head. Neck Surg. 32(13), 963–968 (2018)
29. J. Ibarra, D. Encinas, M. Blanco, S. Barbosa, P. Taboada, J. Juárez et al., Co-encapsulation of magnetic nanoparticles and cisplatin within biocompatible polymers as multifunctional nanoplatforms: synthesis, characterization, and in vitro assays. Mater. Res. Express. 5(1), 15023 (2018)10.1088/2053-1591/aaa0a4 ↗
30. Z. Gao, Y. Li, C. You, K. Sun, P. An, C. Sun et al., Iron oxide nanocarrier-mediated combination therapy of cisplatin and artemisinin for combating drug resistance through highly increased toxic reactive oxygen species generation. ACS Appl. Bio Mater. 1(2), 270–280 (2018)10.1021/acsabm.8b00056 ↗
31. K. Gokduman, Sensitization of cisplatin-resistant ovarian cancer cells by magnetite iron oxide nanoparticles: an in vitro study. Nanomedicine. 14(24), 3177–3191 (2019)10.2217/nnm-2019-0126 ↗
32. M. Mirrahimi, V. Hosseini, S.K. Kamrava, N. Attaran, J. Beik, S. Kooranifar et al., Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe2O3@ au nanocomplex. Artif cells, nanomedicine. Biotechnol. 46(sup1), 241–253 (2018)
33. H. Nosrati, M. Salehiabar, S. Davaran, A. Ramazani, H.K. Manjili, H. Danafar, New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs). Res. Chem. Intermed. 43, 7423–7442 (2017)10.1007/s11164-017-3084-3 ↗
34. W.S. Cho, R. Duffin, F. Thielbeer, M. Bradley, I.L. Megson, W. MacNee et al., Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol. Sci. 126(2), 469–477 (2012)10.1093/toxsci/kfs006 ↗
35. K.N. Han, N.S. Kim, Challenges and opportunities in direct write technology using nano-metal particles. KONA Powder Part. J. 27, 73–83 (2009)10.14356/kona.2009009 ↗
36. I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. Coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275(1), 177–182 (2004)10.1016/j.jcis.2004.02.012 ↗
37. R.C. Murdock, L. Braydich-Stolle, A.M. Schrand, J.J. Schlager, S.M. Hussain, Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 101(2), 239–253 (2008)10.1093/toxsci/kfm240 ↗
38. K. Takahashi, H. Kato, T. Saito, S. Matsuyama, S. Kinugasa, Precise measurement of the size of nanoparticles by dynamic light scattering with uncertainty analysis. Part. Part. Syst. Charact. 25(1), 31–38 (2008)10.1002/ppsc.200700015 ↗
39. A. Hoshino, K. Fujioka, T. Oku, M. Suga, Y.F. Sasaki, T. Ohta et al., Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 4(11), 2163–2169 (2004)10.1021/nl048715d ↗
40. G. Buckton, Interfacial Phenomena in drug Delivery and Targeting, vol. 5 (CRC, 2000)10.1201/9781482296785 ↗
41. A. Pietroiusti, M. Massimiani, I. Fenoglio, M. Colonna, F. Valentini, G. Palleschi et al., Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano. 5(6), 4624–4633 (2011)10.1021/nn200372g ↗
42. J.V. Georgieva, D. Kalicharan, P.O. Couraud, I.A. Romero, B. Weksler, D. Hoekstra et al., Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro. Mol. Ther. 19(2), 318–325 (2011)10.1038/mt.2010.236 ↗
43. A.L. Andrade, D.M. Souza, M.C. Pereira, J.D. Fabris, R.Z. Domingues, Síntese e caracterização de nanopartículas magnéticas revestidas com sílica através de um processo sol-gel. Cerâmica. 55, 420–424 (2009)10.1590/S0366-69132009000400013 ↗
44. D. Schadendorf, van A.C.J. Akkooi, C. Berking, K.G. Griewank, R. Gutzmer, A. Hauschild et al., Melanoma Lancet. 392(10151), 971–984 (2018)10.1016/S0140-6736(18)31559-9 ↗
45. M. Arnold, D. Singh, M. Laversanne, J. Vignat, S. Vaccarella, F. Meheus, A. E. Cust, E. De Vries, D. C. Whiteman, and F. Bray, JAMA Dermatology 158, 495 (2022).10.1001/jamadermatol.2022.0160 ↗
46. S.J. Rogers, E. Puric, B. Eberle, N.R. Datta, S.B. Bodis, Radiotherapy for melanoma: More than DNA damage. Dermatol Res Pract. 2019;201910.1155/2019/9435389 ↗
47. S. Parveen, R. Misra, S.K. Sahoo, Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed. cancer 2017, 47–9810.1201/b22358-3 ↗
48. J.W. Nichols, Y.H. Bae, EPR: evidence and fallacy. J. Control Release. 190, 451–464 (2014)10.1016/j.jconrel.2014.03.057 ↗
49. A. Karageorgis, S. Dufort, L. Sancey, M. Henry, S. Hirsjärvi, C. Passirani, J.-P. Benoit, J. Gravier, I. Texier, and O. Montigon, Sci. Rep. 6, 21417 (2016).10.1038/srep21417 ↗
50. M. Bietenbeck, A. Florian, C. Faber, U. Sechtem, and A. Yilmaz, Int. J. Nanomedicine 11, 3191 (2016).10.2147/IJN.S110542 ↗
51. H. Fakhimikabir, M.B. Tavakoli, A. Zarrabi, A. Amouheidari, S. Rahgozar, The role of folic acid-conjugated polyglycerol coated iron oxide nanoparticles on radiosensitivity with clinical electron beam (6 MeV) on human cervical carcinoma cell line: in vitro study. J. Photochem. Photobiol B Biol. 182, 71–76 (2018)10.1016/j.jphotobiol.2018.03.023 ↗
52. M.M. Fathy, H.M. Fahmy, O.A. Saad, W.M. Elshemey, Silica-coated iron oxide nanoparticles as a novel nano-radiosensitizer for electron therapy. Life Sci. 234, 116756 (2019)10.1016/j.lfs.2019.116756 ↗
53. J. Vega-Chacón, M.I.A. Arbeláez, J.H. Jorge, R.F.C. Marques, M. Jr Jafelicci, pH-responsive poly (aspartic acid) hydrogel-coated magnetite nanoparticles for biomedical applications. Mater. Sci. Eng. C 77, 366–373 (2017)10.1016/j.msec.2017.03.244 ↗
54. M. Kates, A. Date, T. Yoshida, U. Afzal, P. Kanvinde, T. Babu et al., Preclinical evaluation of intravesical cisplatin nanoparticles for non–muscle-invasive bladder cancer. Clin. Cancer Res. 23(21), 6592–6601 (2017)10.1158/1078-0432.CCR-17-1082 ↗
55. Z.M. Avval, L. Malekpour, F. Raeisi, A. Babapoor, S.M. Mousavi, S.A. Hashemi et al., Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. Drug Metab. Rev. 52(1), 157–184 (2020)10.1080/03602532.2019.1697282 ↗
56. E. Kianfar, Magnetic nanoparticles in targeted drug delivery: a review. J. Supercond Nov Magn. 34(7), 1709–1735 (2021)10.1007/s10948-021-05932-9 ↗
57. A. Farzin, S.A. Etesami, J. Quint, A. Memic, A. Tamayol, Magnetic nanoparticles in cancer therapy and diagnosis. Adv. Healthc. Mater. 9(9), 1901058 (2020)10.1002/adhm.201901058 ↗
58. I.M. Zraik, Y. Hess-Busch, Management of chemotherapy side effects and their long-term sequelae. Urologe A 60(7), 862–871 (2021)10.1007/s00120-021-01569-7 ↗
59. Y.Q. Liu, X.L. Wang, D.H. He, Y.X. Cheng, Protection against chemotherapy-and radiotherapy-induced side effects: a review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine. 80, 153402 (2021)10.1016/j.phymed.2020.153402 ↗
60. Y. Hussain, L. Islam, H. Khan, R. Filosa, M. Aschner, S. Javed, Curcumin–cisplatin chemotherapy: a novel strategy in promoting chemotherapy efficacy and reducing side effects. Phyther Res. 35(12), 6514–6529 (2021)10.1002/ptr.7225 ↗
61. Z. Hussain, M.A. Rahim, N. Jan, H. Shah, M. Rawas-Qalaji, S. Khan et al., Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: improved pharmacokinetics, cell internalization and anticancer efficacy. J. Control Release. 335, 130–157 (2021)10.1016/j.jconrel.2021.05.018 ↗
62. A.M. Fard, M.M. Fard, Modeling drug release. Eurasian J. Sci. Tech. 1(1), 284–301 (2021)
63. C. Dahlberg, A. Millqvist-Fureby, M. Schuleit, I. Furó, Relationships between solid dispersion preparation process, particle size and drug release–an NMR and NMR microimaging study. Eur. J. Pharm. Biopharm. 76(2), 311–319 (2010)10.1016/j.ejpb.2010.06.006 ↗